ARCT
Price
$13.78
Change
+$0.16 (+1.17%)
Updated
Jul 3 closing price
Capitalization
369.93M
38 days until earnings call
IMMP
Price
$1.72
Change
+$0.02 (+1.18%)
Updated
Jul 3 closing price
Capitalization
239.43M
54 days until earnings call
Interact to see
Advertisement

ARCT vs IMMP

Header iconARCT vs IMMP Comparison
Open Charts ARCT vs IMMPBanner chart's image
Arcturus Therapeutics Holdings
Price$13.78
Change+$0.16 (+1.17%)
Volume$172.65K
Capitalization369.93M
Immutep
Price$1.72
Change+$0.02 (+1.18%)
Volume$16.5K
Capitalization239.43M
ARCT vs IMMP Comparison Chart in %
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. IMMP commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and IMMP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ARCT: $13.78 vs. IMMP: $1.72)
Brand notoriety: ARCT and IMMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 38% vs. IMMP: 5%
Market capitalization -- ARCT: $369.93M vs. IMMP: $239.43M
ARCT [@Biotechnology] is valued at $369.93M. IMMP’s [@Biotechnology] market capitalization is $239.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileIMMP’s FA Score has 0 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • IMMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ARCT is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 4 TA indicator(s) are bullish while IMMP’s TA Score has 5 bullish TA indicator(s).

  • ARCT’s TA Score: 4 bullish, 4 bearish.
  • IMMP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ARCT and IMMP are a good buy in the short-term.

Price Growth

ARCT (@Biotechnology) experienced а -4.37% price change this week, while IMMP (@Biotechnology) price change was +5.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 11, 2025.

IMMP is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($370M) has a higher market cap than IMMP($239M). ARCT YTD gains are higher at: -18.798 vs. IMMP (-20.737). IMMP has higher annual earnings (EBITDA): -43.83M vs. ARCT (-63.92M). ARCT has more cash in the bank: 217M vs. IMMP (159M). IMMP has less debt than ARCT: IMMP (1.69M) vs ARCT (42.7M). ARCT has higher revenues than IMMP: ARCT (131M) vs IMMP (0).
ARCTIMMPARCT / IMMP
Capitalization370M239M155%
EBITDA-63.92M-43.83M146%
Gain YTD-18.798-20.73791%
P/E RatioN/AN/A-
Revenue131M0-
Total Cash217M159M136%
Total Debt42.7M1.69M2,534%
FUNDAMENTALS RATINGS
ARCT vs IMMP: Fundamental Ratings
ARCT
IMMP
OUTLOOK RATING
1..100
112
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
10086
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
5263
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARCT's Valuation (47) in the Pharmaceuticals Major industry is somewhat better than the same rating for IMMP (83) in the Biotechnology industry. This means that ARCT’s stock grew somewhat faster than IMMP’s over the last 12 months.

IMMP's Profit vs Risk Rating (86) in the Biotechnology industry is in the same range as ARCT (100) in the Pharmaceuticals Major industry. This means that IMMP’s stock grew similarly to ARCT’s over the last 12 months.

ARCT's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as IMMP (96) in the Biotechnology industry. This means that ARCT’s stock grew similarly to IMMP’s over the last 12 months.

ARCT's Price Growth Rating (52) in the Pharmaceuticals Major industry is in the same range as IMMP (63) in the Biotechnology industry. This means that ARCT’s stock grew similarly to IMMP’s over the last 12 months.

ARCT's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as IMMP (100) in the Biotechnology industry. This means that ARCT’s stock grew similarly to IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARCTIMMP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 12 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GSBX26.70N/A
N/A
Golden State Bancorp
CRPHY0.50N/A
N/A
Ceres Power Holdings plc
APTPF0.92N/A
N/A
Airports of Thailand Public Co., Ltd.
CBUMY25.72N/A
N/A
China National Buildings Material
NWRLY0.79N/A
N/A
New World Department Store China Ltd.

ARCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARCT has been loosely correlated with TRDA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ARCT jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARCT
1D Price
Change %
ARCT100%
+1.17%
TRDA - ARCT
52%
Loosely correlated
-0.55%
ABCL - ARCT
51%
Loosely correlated
+1.33%
RXRX - ARCT
51%
Loosely correlated
+1.15%
RGNX - ARCT
51%
Loosely correlated
+1.39%
MRNA - ARCT
50%
Loosely correlated
+0.69%
More

IMMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
+1.18%
PRRUF - IMMP
43%
Loosely correlated
N/A
CALC - IMMP
39%
Loosely correlated
+1.90%
BCRX - IMMP
35%
Loosely correlated
-0.89%
ARCT - IMMP
31%
Poorly correlated
+1.17%
AXON - IMMP
31%
Poorly correlated
+2.70%
More